scholarly journals Characterization of Multiphase Polypyrrole/Vanadium Oxide Nano Composites for a.c. Conductivity and Dielectric Properties

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Nihal B Kottan ◽  
Prajwal M Laxmeesha ◽  
Purnachandra Ganesh K M ◽  
Chaluvaraju BV ◽  
Murugendrappa M V
Keyword(s):  
Vanadium Oxide ◽  
Phase 1 ◽  
Cluster Formation ◽  
Oxide Phase ◽  
Nano Composites ◽  
Phase 2 ◽  
Hydrothermal Technique ◽  
Oxidation Method ◽  
Exponential Increase

Vanadium oxide: Phase-1 and Phase-2 nano powers were synthesized from vanadium pentoxide in the presence of glucose using hydrothermal technique. The polypyrrole/vanadium oxide (PV P-1 and PV P-2) nano composites were synthesized with 15, 30, 45 and 60 weight percents of vanadium oxide: Phase-1 and Phase-2 in pyrrole, by the chemical polymerization (oxidation) method. The SEM micrographs of vanadium oxide: Phase-1 and Phase-2 nano powders have shown  mixture of nano belts & rods and PV P-1 & PV P-2 nano composites indicate that the composites have cluster formation with almost spherical nature particles and form elongated chains at some places. Conductivity versus frequency  plots shown that exponential increase for conductivity. The value of s increases to 1.13x10-3 S/cm for 15 wt. % of VO2 P-1 in polypyrrole & to 2.43x10-3 S/cm for 30 wt. % of VO2 P-2 in polypyrrole at 1 MHz.

scholarly journals Characterization of a Monoclonal Antibody Directed against Salmonella enterica Serovar Typhimurium and Serovar [4,5,12:i:−]

2009 ◽  
Vol 75 (5) ◽  
pp. 1345-1354 ◽  
Author(s):  
A. Rementeria ◽  
A. B. Vivanco ◽  
A. Ramirez ◽  
F. L. Hernando ◽  
J. Bikandi ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Western Blotting ◽  
Salmonella Enterica ◽  
Phase 1 ◽  
Enzyme Linked Immunosorbent Assay ◽  
Phase 2 ◽  
Serovar Typhimurium ◽  
Antigenic Complex ◽  
Dot Blotting

ABSTRACT Flagellar extracts of Salmonella enterica serovars expressing phase 2 H1 antigenic complex (H:1,2, H:1,5, H:1,6, and H:1,7) and a mutant flagellin obtained by site-directed mutagenesis of the fljB gene from serovar Typhimurium at codon 218, transforming threonine to alanine, expressed in Escherichia coli (fljB218 A ) were used to analyze the H1 antigenic complex. Cross-reactions were detected by Western blotting and dot blotting using commercial polyclonal antibodies against the different wild-type extracts and mutant FljB218A. Therefore, we produced a monoclonal antibody (MAb), 23D4, isotyped as immunoglobulin M, against H:1,2 S. enterica serovar Typhimurium flagellin. The mutant flagellin was not recognized by this MAb. When a large number of phase 1 and phase 2 flagellin antigens of different serovars were used to characterize the 23D4 MAb, only extracts of serovars Typhimurium and [4,5,12:i:−] reacted. The protein composition of phase 1 and phase 2 extracts and highly purified H:1,2 flagellin from serovar Typhimurium strain LT2 and extract of strain 286 (serovar [4,5,12:i:−]), which reacted with the MAb, was studied. Phase 2 flagellin (FljBH:1,2) was detected in phase 1 and phase 2 flagellar heat extracts of serovar Typhimurium and was the single protein identified in all spots of purified H:1,2 flagellin. FliC, FlgK, and other proteins were detected in some immunoreactive spots and in the flagellar extract of serovar [4,5,12:i:−]. Immunoelectron microscopy of complete bacteria with 23D4 showed MAb attachment at the base of flagella, although the MAb failed to recognize the filament of flagella. Nevertheless, the results obtained by the other immunological tests (enzyme-linked immunosorbent assay, Western blotting, and dot blotting) indicate a reaction against flagellins. The epitopes could also be shared by other proteins on spots where FljB is not present, such as aminopeptidase B, isocitrate lyase, InvE, EF-TuA, enolase, DnaK, and others. In conclusion, MAb 23D4 can be useful for detection and diagnostic purposes of S. enterica serovar Typhimurium and serovar [4,5,12:i:−] and could be also helpful for epitope characterization of flagellum-associated antigens.

scholarly journals Analysis of high-intensity efforts in brazilian professional soccer players

2017 ◽  
Vol 18 (5) ◽  
Author(s):  
Felipe Arruda Moura ◽  
Ana Lorena Marche ◽  
Fabio Giuliano Caetano ◽  
Ricardo Da Silva Torres ◽  
Luiz Eduardo Barreto Martins ◽  
...  
Keyword(s):  
High Intensity ◽  
Phase 1 ◽  
S Phase ◽  
Soccer Players ◽  
Phase 2 ◽  
Velocity Increase ◽  
Professional Soccer ◽  
The Moment ◽  
Local Value

AbstractPurpose. The study aim was to characterize high-intensity efforts (HIEs) of soccer players. Methods. The HIE features were quantified according to playing positions, with the consideration of the moment of initial velocity increase, which precedes the velocity threshold. The total of 107 players of Brazilian first division championship were analysed with the automatic tracking method. HIE phase 1 began at the minimum local value and finished when the velocity reached 6.4 m/s. Phase 2 began immediately when the velocity exceeded 6.4 m/s and finished with the velocity lower than 6.4 m/s. Results. External defenders and forwards performed a greater (p < 0.01; d: 1.01-1.17) number of HIEs (40.0 ± 13.5 and 34.9 ± 6.6, respectively) than central defenders (26.6 ± 9.2). With respect to the distance covered and duration of phase 2, external defenders covered a greater (p < 0.01; d: 0.45-0.47) distance (13.5 ± 4.5 m) and spent more (p < 0.01; d: 0.24-0.26) time (1.8 ± 1.3 s) than central defenders (11.5 ± 4.3 m; 1.5 ± 1.2 s), forwards (11.4 ± 4.4 m; 1.5 ± 0.9 s), central midfielders (11.5 ± 4.4 m; 1.5 ± 1.2 s), and external midfielders (11.4 ± 4.6 m; 1.5 ± 1.1 s). Players performed a greater (p = 0.03; d: 2.29-5.17) number of HIEs with more than 120 s of recovery time compared with other time categories. Conclusions. The better characterization of HIE physical demands during soccer matches provides insights for coaches to plan a more specific physical training for professional players.

Characterization of Supported Metal Oxides by Laser Raman Spectroscopy: Supported Vanadium Oxide on Al2O3 and TiO2

1987 ◽  
Vol 111 ◽  
Author(s):  
Israel E. Wachs ◽  
Franklin D. Hardcastle ◽  
Shirley S. Chan
Keyword(s):  
Raman Spectroscopy ◽  
Vanadium Oxide ◽  
Metal Oxides ◽  
Surface Area ◽  
Strong Interaction ◽  
Oxide Phase ◽  
Laser Raman Spectroscopy ◽  
Laser Raman ◽  
Oxide Support

AbstractThe interaction of supported vanadium oxide with Al2O3 and TiO2 substrates is examined with Raman spectroscopy. The Raman spectra of the supported vanadium oxide reveal that the strong interaction of the vanadium oxide with the Al2O3 and TiO2 supports results in the formation of an atomically dispersed surface vanadium oxide phase as well as supported crystalline V2O5. The relative concentrations of the atomically dispersed surface vanadium oxide and crystalline V2O5 depend on the vanadium oxide loading and the surface area of the oxide support.

scholarly journals NEMO: A PROJECT FOR A KM3 UNDERWATER DETECTOR FOR ASTROPHYSICAL NEUTRINOS IN THE MEDITERRANEAN SEA

2007 ◽  
Vol 22 (21) ◽  
pp. 3509-3520 ◽  
Author(s):  
I. AMORE ◽  
S. AIELLO ◽  
M. AMBRIOLA ◽  
F. AMELI ◽  
M. ANGHINOLFI ◽  
...  
Keyword(s):  
Mediterranean Sea ◽  
Feasibility Study ◽  
Phase 1 ◽  
Neutrino Telescope ◽  
Phase 2 ◽  
Astrophysical Neutrinos ◽  
The Status ◽  
The Mediterranean

The status of the project is described: the activity on long term characterization of water optical and oceanographic parameters at the Capo Passero site candidate for the Mediterranean km3 neutrino telescope; the feasibility study; the physics performances and underwater technology for the km3; the activity on NEMO Phase 1, a technological demonstrator that has been deployed at 2000 m depth 25 km offshore Catania; the realization of an underwater infrastructure at 3500 m depth at the candidate site (NEMO Phase 2).

Rationalization and internalization

2001 ◽  
Vol 60 (4) ◽  
pp. 215-230 ◽  
Author(s):  
Jean-Léon Beauvois
Keyword(s):  
Phase 1 ◽  
Facilitatory Effect ◽  
Phase 2 ◽  
Causal Explanations ◽  
Reduction Effect ◽  
Dissonance Reduction

After having been told they were free to accept or refuse, pupils aged 6–7 and 10–11 (tested individually) were led to agree to taste a soup that looked disgusting (phase 1: initial counter-motivational obligation). Before tasting the soup, they had to state what they thought about it. A week later, they were asked whether they wanted to try out some new needles that had supposedly been invented to make vaccinations less painful. Agreement or refusal to try was noted, along with the size of the needle chosen in case of agreement (phase 2: act generalization). The main findings included (1) a strong dissonance reduction effect in phase 1, especially for the younger children (rationalization), (2) a generalization effect in phase 2 (foot-in-the-door effect), and (3) a facilitatory effect on generalization of internal causal explanations about the initial agreement. The results are discussed in relation to the distinction between rationalization and internalization.

PENERAPAN MODEL QUANTUM LEARNING UNTUK MENINGKATKAN HASIL BELAJAR AUTOCAD SISWA KELAS X TEKNIK PEMESINAN SMK NEGERI 1 STABAT

2013 ◽  
Vol 5 (1) ◽  
Author(s):  
Abdul Hasan Saragih
Keyword(s):  
Positive Response ◽  
Phase 1 ◽  
First Grade ◽  
Learning Model ◽  
Second Phase ◽  
Phase 2 ◽  
Phase 3 ◽  
The Third ◽  
Third Phase ◽  
Quantum Learning

This classroom research was conducted on the autocad instructions to the first grade of mechinary class of SMK Negeri 1 Stabat aiming at : (1) improving the student’ archievementon autocad instructional to the student of mechinary architecture class of SMK Negeri 1 Stabat, (2) applying Quantum Learning Model to the students of mechinary class of SMK Negeri 1 Stabat, arising the positive response to autocad subject by applying Quantum Learning Model of the students of mechinary class of SMK Negeri 1 Stabat. The result shows that (1) by applying quantum learning model, the students’ achievement improves significantly. The improvement ofthe achievement of the 34 students is very satisfactory; on the first phase, 27 students passed (70.59%), 10 students failed (29.41%). On the second phase 27 students (79.41%) passed and 7 students (20.59%) failed. On the third phase 30 students (88.24%) passed and 4 students (11.76%) failed. The application of quantum learning model in SMK Negeri 1 Stabat proved satisfying. This was visible from the activeness of the students from phase 1 to 3. The activeness average of the students was 74.31% on phase 1,81.35% on phase 2, and 83.63% on phase 3. (3) The application of the quantum learning model on teaching autocad was very positively welcome by the students of mechinary class of SMK Negeri 1 Stabat. On phase 1 the improvement was 81.53% . It improved to 86.15% on phase 3. Therefore, The improvement ofstudent’ response can be categorized good.

In situ deteriorating patient simulation in general practice

2020 ◽  
Vol 70 (suppl 1) ◽  
pp. bjgp20X711425
Author(s):  
Joanna Lawrence ◽  
Petronelle Eastwick-Field ◽  
Anne Maloney ◽  
Helen Higham
Keyword(s):  
Life Support ◽  
Early Recognition ◽  
Phase 1 ◽  
Patient Simulation ◽  
Medical Emergency ◽  
Phase 2 ◽  
Action Plans ◽  
Integrated Simulation ◽  
Deteriorating Patient

BackgroundGP practices have limited access to medical emergency training and basic life support is often taught out of context as a skills-based event.AimTo develop and evaluate a whole team integrated simulation-based education, to enhance learning, change behaviours and provide safer care.MethodPhase 1: 10 practices piloted a 3-hour programme delivering 40 minutes BLS and AED skills and 2-hour deteriorating patient simulation. Three scenarios where developed: adult chest pain, child anaphylaxis and baby bronchiolitis. An adult simulation patient and relative were used and a child and baby manikin. Two facilitators trained in coaching and debriefing used the 3D debriefing model. Phase 2: 12 new practices undertook identical training derived from Phase 1, with pre- and post-course questionnaires. Teams were scored on: team working, communication, early recognition and systematic approach. The team developed action plans derived from their learning to inform future response. Ten of the 12 practices from Phase 2 received an emergency drill within 6 months of the original session. Three to four members of the whole team integrated training, attended the drill, but were unaware of the nature of the scenario before. Scoring was repeated and action plans were revisited to determine behaviour changes.ResultsEvery emergency drill demonstrated improved scoring in skills and behaviour.ConclusionA combination of: in situ GP simulation, appropriately qualified facilitators in simulation and debriefing, and action plans developed by the whole team suggests safer care for patients experiencing a medical emergency.

Clinical Drug Development for the Treatment of Pulmonary Arterial Hypertension: Collaboration With the Pharmaceutical Industry and Regulatory Agencies

2010 ◽  
Vol 9 (4) ◽  
pp. 214-219
Author(s):  
Robyn J. Barst
Keyword(s):  
Clinical Trials ◽  
Pulmonary Arterial Hypertension ◽  
Drug Development ◽  
Phase 1 ◽  
Preclinical Studies ◽  
Phase 2 ◽  
Phase 3 ◽  
Preclinical Testing ◽  
New Drug ◽  
Pulmonary Arterial

Drug development is the entire process of introducing a new drug to the market. It involves drug discovery, screening, preclinical testing, an Investigational New Drug (IND) application in the US or a Clinical Trial Application (CTA) in the EU, phase 1–3 clinical trials, a New Drug Application (NDA), Food and Drug Administration (FDA) review and approval, and postapproval studies required for continuing safety evaluation. Preclinical testing assesses safety and biologic activity, phase 1 determines safety and dosage, phase 2 evaluates efficacy and side effects, and phase 3 confirms efficacy and monitors adverse effects in a larger number of patients. Postapproval studies provide additional postmarketing data. On average, it takes 15 years from preclinical studies to regulatory approval by the FDA: about 3.5–6.5 years for preclinical, 1–1.5 years for phase 1, 2 years for phase 2, 3–3.5 years for phase 3, and 1.5–2.5 years for filing the NDA and completing the FDA review process. Of approximately 5000 compounds evaluated in preclinical studies, about 5 compounds enter clinical trials, and 1 compound is approved (Tufts Center for the Study of Drug Development, 2011). Most drug development programs include approximately 35–40 phase 1 studies, 15 phase 2 studies, and 3–5 pivotal trials with more than 5000 patients enrolled. Thus, to produce safe and effective drugs in a regulated environment is a highly complex process. Against this backdrop, what is the best way to develop drugs for pulmonary arterial hypertension (PAH), an orphan disease often rapidly fatal within several years of diagnosis and in which spontaneous regression does not occur?

Sign in / Sign up

Export Citation Format

Share Document